Clinical efficacy of modified bianchi orchiopexy(MBO) in the treatment of palpable cryptorchidism

Author:

Zhang Cheng,Lv Guangwei,Li Xiaoxia,Wu Peng,Shang Yaru,Zhang Xiongzhou,Yang Zenglei,Zhang Gang,Bai Ansheng

Abstract

Abstract

Background The advantages and disadvantages of the two types of operation were discussed by comparing the clinical efficacy of modified bianchi orchiopexy(MBO trans-scrotal midline incision ) and traditional laparoscopic orchiopexy (TLO). Methods A retrospective analysis was conducted on 100 cases of palpable cryptorchidism admitted to our hospital from October 2021 to October 2022. Patients were categorized into the MBO group (n = 50) and TLO group (n = 50) based on the surgical approach. The differences in the rate of operation success,operation time,hospitalization expenses and postoperative complications were compared between the two groups. Results The MBO group demonstrates a surgery success rate of 94%, while the TLO group achieves a success rate of 96%, with no statistically significant difference (P > 0.05). The differences in surgical duration and hospitalization expenses between the two groups are statistically significant(P < 0.05). Regarding postoperative complications, the MBO group exhibits 2 cases of testicular retraction, and the TLO group has 3 cases, but the difference is not statistically significant (P > 0.05). Neither group of patients experiences testicular atrophy, inguinal hernia, hydrocele, scrotal hematoma, nor encounters poor wound healing. Conclusion Both surgical methods are equally safe and effective. The transscrotal incision offers advantages in terms of surgical duration,hospitalization expenses and aesthetic appeal compared to the traditional laparoscopic surgery incision, aligning more with the concept of minimally invasive procedures,thus warranting clinical promotion.

Publisher

Springer Science and Business Media LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3